An interventional study of Breast Cancer Patient Empowerment Program (BreastCancerPEP) in Breast Cancer, sponsored by Gabriela Ilie. Not yet recruiting at 1 site in Canada. Open to female participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-02-06.
Sponsored by Gabriela Ilie · Not applicable, Interventional, and Supportive care
This study is evaluating a six-month, home-based Patient Empowerment Program (Breast Cancer PEP) for women receiving treatment for newly diagnosed invasive breast cancer. The program provides daily guidance on physical activity, arm and shoulder rehabilitation, stress-reduction practices, healthy lifestyle habits, and social support, all delivered through online videos, emails, and optional group sessions.
The purpose of the study is to learn whether this program can reduce psychological distress and improve overall well-being compared with standard cancer care. Psychological distress will be measured using a simple questionnaire called the Kessler Psychological Distress Scale (K10). The study will also look at general health, quality of life, and participants' experiences with the program.
A total of 160 women across Nova Scotia will take part. Participants will be randomly assigned to start the program right away or to receive standard care for six months before getting access to the program. Everyone will complete online questionnaires at the beginning of the study and again at 6 and 12 months. A small number of participants may also be invited to take part in optional interviews to share their experiences.
Researchers will also explore how participants use the digital program, what parts are most helpful, and whether the program could be offered more broadly in the future. The trial is being conducted across all Nova Scotia Health zones and coordinated through the QEII Health Sciences Centre.
Breast Cancer PEP (BC-PEP) is a six-month, home-based, digitally delivered supportive-care program designed for individuals undergoing treatment for newly diagnosed invasive breast cancer. The program integrates physical activity, upper-limb rehabilitation, mindfulness, nutrition education, and self-management strategies. BC-PEP is based on prior PEP programs evaluated in Atlantic Canada, which demonstrated high feasibility and strong participant engagement.
In this randomized, wait-list-controlled trial, participants assigned to the early-intervention arm begin the 6-month BC-PEP program immediately after randomization, while participants in the wait-list control arm receive standard care for 6 months before initiating the same program. All participants are followed for approximately 12 months to assess intervention effects and longer-term outcomes. Randomization and allocation procedures are conducted centrally, and the study is implemented across multiple Nova Scotia Health sites.
Intervention Delivery:
BC-PEP is delivered primarily through automated daily emails generated via REDCap over 182 consecutive days. Each email provides a structured set of activities, including:
Progressive aerobic activity designed to meet oncology-specific guidelines Twice-weekly resistance-training sessions using household equipment or elastic bands Daily stretching and upper-limb rehabilitation exercises aligned with surgical recovery timelines A 10-minute daily mindfulness or relaxation practice Short educational modules addressing sleep, stress coping, communication, body image, and nutrition
Participants have access to a video library with instructional content, may engage in an optional peer-support "buddy system," and are invited to monthly videoconference sessions with study clinicians.
Implementation and Engagement Monitoring Engagement metrics are collected throughout the program, including weekly adherence surveys, email-open rates, video-view data, and participation in monthly sessions. Implementation outcomes will be examined using a Hybrid Type I effectiveness-implementation approach guided by the RE-AIM framework.
This digital, low-cost program is designed to be scalable and accessible across diverse geographic regions. Study findings are intended to inform the effectiveness and implementation potential of BC-PEP as part of routine supportive cancer care.
14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.
This study's planned enrollment of 160 is above the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Gabriela Ilie is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants must meet all of the following criteria:
Exclusion Criteria
Participants will be excluded if any of the following apply:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumour. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adjuvant and neoadjuvant
Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumour. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to the Early Intervention arm will begin the Breast Cancer Patient Empowerment Program (Breast Cancer PEP) immediately after baseline assessment. The 6-month, home-based digital program includes daily emails with structured physical activity guidance, arm and shoulder rehabilitation exercises, mindfulness practices, and lifestyle education modules, along with optional peer-support check-ins and monthly videoconference sessions. Participants complete weekly self-report compliance surveys throughout the 6-month program.
Behavioral: Breast Cancer Patient Empowerment Program (BreastCancerPEP)
Participants randomized to the Delayed Intervention arm receive usual care for the first 6 months following baseline assessment. No program materials or intervention content are provided during this period. At approximately 6 months, participants complete follow-up assessments and then begin the same 6-month Breast Cancer Patient Empowerment Program (Breast Cancer PEP) as the Early Intervention arm, including daily digital content, rehabilitation exercises, mindfulness practices, lifestyle modules, optional peer-support, and monthly videoconference sessions.
Behavioral: Breast Cancer Patient Empowerment Program (BreastCancerPEP)
The Breast Cancer Patient Empowerment Program (Breast Cancer PEP) is a 6-month, home-based digital behavioural intervention delivered through daily automated emails containing structured physical activity guidance, resistance-band and body-weight strength training, yoga and stretching routines, arm and shoulder rehabilitation exercises, mindfulness and relaxation practices, and lifestyle education modules. Optional peer-support check-ins and monthly videoconference group sessions are included. Intervention content is standardized through a 182-day pre-programmed email and video library. Participants in both study arms receive the same intervention content, with timing dependent on randomization assignment.
Proportion of participants with clinically significant psychological distress (Kessler Psychological Distress Scale-10 ≥20)
Proportion of participants scoring ≥20 on the Kessler Psychological Distress Scale-10 (K10) at 6 months after randomization. The K10 is a validated 10-item measure of psychological distress with scores ranging from 10-50, where higher scores indicate worse distress.
Time frame: 6 months after randomization (Day 183 ± 2 days)
Change in psychological distress (Kessler Psychological Distress Scale-10 total score)
Change in total score on the Kessler Psychological Distress Scale-10 (K10) from baseline to 6 and 12 months. The K10 ranges from 10-50, with higher scores indicating worse distress. This outcome complements the primary binary measure by assessing psychological distress as a continuous variable.
Time frame: Baseline to 6 months; baseline to 12 months
Change in health-related quality of life (SF-12v2 Physical and Mental Component Scores)
Change in SF-12v2 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores from baseline to 6 and 12 months. Scores range from 0-100, with higher scores indicating better health status.
Time frame: Baseline to 6 months; baseline to 12 months
Change in health utility score (SF-6D)
Change in SF-6D health utility score derived from SF-12v2 responses. Scores range from approximately 0.29-1.00, with higher scores indicating better health-related quality of life.
Time frame: Baseline to 6 months; baseline to 12 months
Change in cancer-specific quality of life (EORTC QLQ-C30)
Change in EORTC QLQ-C30 domain scores. All scales transformed to 0-100. Higher scores indicate better functioning for functional scales and worse symptoms for symptom scales; higher global health = better QoL.
Time frame: Baseline to 6 months; Baseline to 12 months.
Change in breast cancer-specific quality of life (EORTC QLQ-BR23)
Change in QLQ-BR23 domain scores (0-100). Higher functional scores indicate better functioning; higher symptom scores indicate worse symptoms.
Time frame: Baseline to 6 months; Baseline to 12 months.
Change in self-efficacy (Self-Efficacy for Managing Chronic Disease 6-item Scale)
Change in SEMCD-6 total score. Scores range 1-10; higher scores indicate greater self-efficacy.
Time frame: Baseline to 6 months; baseline to 12 months
Change in patient activation (Patient Activation Measure-13)
Change in PAM-13 total score. Scores range 0-100; higher scores indicate greater activation.
Time frame: Baseline to 6 months; baseline to 12 months
Change in generalized anxiety symptoms (GAD-7)
Change in GAD-7 total score. Scores range 0-21; higher scores indicate greater anxiety. Time Frame: Baseline to 6 months; Baseline to 12 months.
Time frame: Baseline to 6 months; baseline to 12 months
Change in cognitive function (PROMIS® Short Form v2.0 - Cognitive Function 8a)
Change in PROMIS Cognitive Function 8a T-score. T-scores typically range \~20-80; higher T-scores indicate better cognitive function.
Time frame: Baseline to 6 months; baseline to 12 months
Change in upper-limb disability and symptoms (QuickDASH)
Change in QuickDASH total score. Scores range 0-100; higher scores indicate greater disability/symptoms (worse function).
Time frame: Baseline to 6 months; baseline to 12 months
Change in menopause symptoms (Menopause Quick 6)
Change in MQ-6 total score (6 items; scale scoring varies by version). Higher scores indicate more severe menopause symptoms.
Time frame: Baseline to 6 months; baseline to 12 months
Change in social support (Medical Outcomes Study Social Support Survey)
Change in MOS-SSS summary score (and/or subscales). Scores transformed to 0-100; higher scores indicate greater perceived social support.
Time frame: Baseline to 6 months; baseline to 12 months
Change in body weight (self-reported kilograms)
Change in participant self-reported body weight (kg) from baseline to 6 and 12 months.
Time frame: Baseline to 6 months; baseline to 12 months
Change in diet quality (Rapid Eating Assessment for Participants - Shortened v2)
Change in REAP-S v2 total score. Scores range from 0-60; higher scores indicate healthier dietary habits.
Time frame: Baseline to 6 months; baseline to 12 months
Self-reported adherence to cancer treatment
Proportion of participants reporting full adherence to prescribed cancer treatment(s) via questionnaire.
Time frame: Baseline to 6 months; baseline to 12 months
Clinically verified adherence to cancer treatment
Proportion of participants documented as adherent in medical records.
Time frame: Baseline to 6 months; baseline to 12 months
Number of hospitalizations (administrative data)
Count of all-cause hospitalizations per participant from linked administrative data.
Time frame: Baseline to 6 months; baseline to 12 months
Number of physician billing events (administrative data)
Count of physician billing events per participant from linked provincial administrative databases.
Time frame: Baseline to 6 months; baseline to 12 months
Participant satisfaction with program components (0-10 rating scale)
Participant-reported satisfaction with individual components of the Breast Cancer PEP program, assessed via a post-intervention survey. Each component (e.g., aerobic exercise, diet, mindfulness practices) is rated on a 0-10 Likert-type scale, where 0 = not at all helpful and 10 = extremely helpful.
Time frame: At 6 months (post-intervention)
Participant adherence to program activities (weekly self-report surveys)
Percentage of prescribed weekly PEP activities completed, based on participant self-report surveys.
Time frame: Throughout 6-month intervention
Change in physical activity (self-reported minutes per week)
Change in self-reported weekly minutes of moderate-to-vigorous physical activity.
Time frame: Baseline to 6 months; baseline to 12 months
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gabriela Ilie